BioData World Congress
BioData World Congress transpiring on the 28-29th November in Basel is the worlds-leading event for individuals working within Big Data and AI in life sciences and healthcare research. to drive forwards big data use in Pharmaceuticals.
The event was originally created with the support of leading institutes such as EMBL-EBI, Genomics England, Sanger Institute and the NHS and has since been commissioned by Roche and Merck along with others. Biodata brings together global heads of IT, data, analytics, digital, CDOs, CIOs, bioinformatics, genetics, oncology, rare disease, computational biology, translational medicine etc from leading pharmaceutical companies. BioData takes place over 12 tracks this year, including: Storage, IT and Management, Bioinformatics, AI and Machine Learning, Big Data in Cancer, Data Integration & Infrastructure, Big Data in Rare Diseases, Analytics Platforms and Data Sets, Next Gen Sequencing, Data Management, Genomics in Clinical Trials, Real World Evidence and Precision Medicine along with a Hackathon and two Start up Streams.
We have moved the 2018 edition to Basel as the Canton of Basel-Stadt are investing in the event long term. This will put us on the doorstep of a number of leading industry individuals such as Novartis and Roche.
There will be 200 speakers and 700+ attendees. In terms of speakers 70% will be pharma, 20% research institutes, 10% Academia. 70% of the attendees will be European based, 20% US and 10% rest of world.
The Biodata World Congress presents a lucrative opportunity for you to meet new customers and to grow your client base as you benefit from being able to sell to both our buy-side and sell-side audience.